Robin Dore, MD, Rheumatology, Tustin, CA, St. Joseph Hospital Orange

RobinKDoreMD

Rheumatology Tustin, CA

Rheumatoid Arthritis & Related, Spondyloarthropathy

Clinical Professor of Medicine, UCLA

Dr. Dore is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dore's full profile

Already have an account?

Education & Training

  • UCLA Medical Center
    UCLA Medical CenterFELLOWSHIP
  • UCLA Medical Center
    UCLA Medical CenterRESIDENCY
  • UCLA Medical Center
    UCLA Medical CenterINTERNSHIP
  • University of California Irvine School of Medicine
    University of California Irvine School of MedicineMEDICAL_SCHOOL
  • Pomona CollegeOTHER_TRAINING

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1976 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Osteoporosis: Fractures and Key Risk Factors.  
    Dore RK, Female Patient; March Supp:5-12
  • Guidelines for Rheumatology Referral.  
    Dore RK, et al, American College of Rheumatology
  • Efficacy and Safety of Etodolac and Naproxen in Patients with Osteoarthritis of the Knee: A Double-Blind, Placebo Controlled Study.  
    Dore RK, et al, Clinical Therapeutics, Vol. 17, No 4, 656-666
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Denosumab Increases Bone Mineral Density in Patients With Rheumatoid Arthritis: 12-month Results.
    Dore R et al, ASBMR
  • Inhibiting RANKL with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis: 6month results from a randomized, placebo-controlled study.
    Dore RK et al, EULAR
  • RANKL Inhibition with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis.
    Dore RK et al, ECCEO, Porto, Portugal
  • Join now to see all

Press Mentions

  • Webinar: What Do These Numbers Mean? Decoding Your Arthritis Labs
    Webinar: What Do These Numbers Mean? Decoding Your Arthritis LabsAugust 15, 2019 00:25
  • Sandoz Will Appeal District Court of New Jersey Ruling in Biosimilar Erelzi (Etanercept-Szzs) US Patent Case
    Sandoz Will Appeal District Court of New Jersey Ruling in Biosimilar Erelzi (Etanercept-Szzs) US Patent CaseAugust 15, 2019 00:25
  • Three Medical Groups Join Push to Lower Drug Prices
    Three Medical Groups Join Push to Lower Drug PricesJune 22, 2017 10:50
  • Join now to see all

Professional Memberships

Hospital Affiliations